- Home
- EEX vs CATX Comparison
EEX vs CATX Comparison
Compare EEX & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEX
- CATX
- Stock Information
- Founded
- EEX 2013
- CATX 1983
- Country
- EEX United States
- CATX United States
- Employees
- EEX N/A
- CATX N/A
- Industry
- EEX Advertising
- CATX Medical/Dental Instruments
- Sector
- EEX Consumer Discretionary
- CATX Health Care
- Exchange
- EEX Nasdaq
- CATX Nasdaq
- Market Cap
- EEX 883.0M
- CATX 782.7M
- IPO Year
- EEX 2017
- CATX N/A
- Fundamental
- Price
- EEX $4.87
- CATX $3.48
- Analyst Decision
- EEX Strong Buy
- CATX Strong Buy
- Analyst Count
- EEX 2
- CATX 9
- Target Price
- EEX $7.90
- CATX $21.63
- AVG Volume (30 Days)
- EEX 116.9K
- CATX 838.3K
- Earning Date
- EEX 10-30-2024
- CATX 11-12-2024
- Dividend Yield
- EEX 1.26%
- CATX N/A
- EPS Growth
- EEX N/A
- CATX N/A
- EPS
- EEX N/A
- CATX N/A
- Revenue
- EEX $393,500,000.00
- CATX $1,557,000.00
- Revenue This Year
- EEX $5.54
- CATX N/A
- Revenue Next Year
- EEX $7.75
- CATX N/A
- P/E Ratio
- EEX N/A
- CATX N/A
- Revenue Growth
- EEX 4.96
- CATX N/A
- 52 Week Low
- EEX $3.92
- CATX $2.30
- 52 Week High
- EEX $7.05
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- EEX 54.31
- CATX 10.37
- Support Level
- EEX $4.57
- CATX $11.40
- Resistance Level
- EEX $4.83
- CATX $12.82
- Average True Range (ATR)
- EEX 0.16
- CATX 0.83
- MACD
- EEX 0.03
- CATX -0.68
- Stochastic Oscillator
- EEX 79.03
- CATX 0.00
About EEX Emerald Holding Inc.
Emerald Holding Inc is an operator of B2B trade shows in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry, Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. Majority of the revenue for the company is generated from its Connections segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.